Rs1113129

Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids.

Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.

Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies.


 * is_associated_with_disease::Toxic encephalopathy
 * is_associated_with_disease::Kidney disease